| 000 | 01471 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518005009.0 | ||
| 264 | 0 | _c20200619 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1578-8989 | ||
| 024 | 7 |
_a10.1016/j.medcli.2018.08.015 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSánchez-Escamilla, Miriam | |
| 245 | 0 | 0 |
_aCAR T cells: The future is already present. _h[electronic resource] |
| 260 |
_bMedicina clinica _c04 2019 |
||
| 300 |
_a281-286 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAccreditation |
| 650 | 0 | 4 |
_aAntigens, CD19 _xtherapeutic use |
| 650 | 0 | 4 | _aBiological Products |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 |
_aHospital Units _xorganization & administration |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy, Adoptive _xadverse effects |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xtherapy |
| 650 | 0 | 4 |
_aPatient Care Team _xorganization & administration |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xtherapy |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Chimeric Antigen _xadministration & dosage |
| 700 | 1 | _aYáñez San Segundo, Lucrecia | |
| 700 | 1 | _aUrbano-Ispizua, Álvaro | |
| 700 | 1 | _aPerales, Miguel-Ángel | |
| 773 | 0 |
_tMedicina clinica _gvol. 152 _gno. 7 _gp. 281-286 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2018.08.015 _zAvailable from publisher's website |
| 999 |
_c29009112 _d29009112 |
||